Suppr超能文献

一种用于研究保乳治疗后脂肪移植安全性的体外方法。

An In Vitro Approach for Investigating the Safety of Lipotransfer after Breast-Conserving Therapy.

作者信息

Promny Theresa, Kutz Chiara-Sophia, Jost Tina, Distel Luitpold V, Kadam Sheetal, Schmid Rafael, Arkudas Andreas, Horch Raymund E, Kengelbach-Weigand Annika

机构信息

Department of Plastic and Hand Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

出版信息

J Pers Med. 2022 Aug 5;12(8):1284. doi: 10.3390/jpm12081284.

Abstract

The application of lipotransfer after breast-conserving therapy (BCT) and irradiation in breast cancer patients is an already widespread procedure for reconstructing volume deficits of the diseased breast. Nevertheless, the safety of lipotransfer has still not been clarified yet due to contradictory data. The goal of this in vitro study was to further elucidate the potential effects of lipotransfer on the irradiated remaining breast tissue. The mammary epithelial cell line MCF-10A was co-cultured with the fibroblast cell line MRC-5 and irradiated with 2 and 5 Gy. Afterwards, cells were treated with conditioned medium (CM) from adipose-derived stem cells (ADSC), and the effects on the cellular functions of MCF-10A cells and on gene expression at the mRNA level in MCF-10A and MRC-5 cells were analyzed. Treatment with ADSC CM stimulated transmigration and invasion and decreased the surviving fraction of MCF-10A cells. Further, the expression of cytokines, extracellular, and mesenchymal markers was enhanced in mammary epithelial cells. Only an effect of ADSC CM on irradiated fibroblasts could be observed. The present data suggest epithelial-mesenchymal transition-like changes in the epithelial mammary breast cell line. Thus, the benefits of lipotransfer after BCT should be critically weighed against its possible risks for the affected patients.

摘要

在乳腺癌患者的保乳治疗(BCT)和放疗后应用脂肪移植,是一种已广泛用于修复患侧乳房体积缺损的方法。然而,由于数据相互矛盾,脂肪移植的安全性仍未得到明确。这项体外研究的目的是进一步阐明脂肪移植对放疗后剩余乳腺组织的潜在影响。将乳腺上皮细胞系MCF-10A与成纤维细胞系MRC-5共培养,并用2 Gy和5 Gy进行照射。之后,用脂肪来源干细胞(ADSC)的条件培养基(CM)处理细胞,并分析其对MCF-10A细胞的细胞功能以及MCF-10A和MRC-5细胞中mRNA水平基因表达的影响。用ADSC CM处理可刺激迁移和侵袭,并降低MCF-10A细胞的存活分数。此外,乳腺上皮细胞中细胞因子、细胞外和间充质标志物的表达增强。仅观察到ADSC CM对受照射成纤维细胞有影响。目前的数据表明,乳腺上皮细胞系存在上皮-间质转化样变化。因此,对于受影响的患者,应严格权衡BCT后脂肪移植的益处及其可能的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354d/9409821/f253e798f4e5/jpm-12-01284-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验